Therapeutic Asset Ratings
3,774 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Jcar017 (Lisocabtagene Maraleucel)
High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit
Patrick C. Johnson, MD
P2
CCC
(53)
Jcar017 (Lisocabtagene Maraleucel)
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
Patrick C. Johnson, MD
P2
CCC
(53)
Jcar017 (Lisocabtagene Maraleucel)
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
Patrick C. Johnson, MD
P2
CCC
(53)
Jcar017 (Lisocabtagene Maraleucel)
Richter Transformation
Aseel Alsouqi
P2
CCC
(53)
Jcar017 (Lisocabtagene Maraleucel)
Aggressive B-Cell Non-Hodgkin Lymphoma
Patrick C. Johnson, MD
P2
CCC
(53)
Jcar017 (Lisocabtagene Maraleucel)
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Patrick C. Johnson, MD
P2
CCC
(53)
Jcar017 (Lisocabtagene Maraleucel)
Transformed Follic Lymph to Diff Large B-Cell Lymphoma
SWOG Cancer Research Network
P2
CCC
(53)
Jwcar029
CNS Lymphoma
Zhengzhou University
P2
CCC
(53)
Jwcar029
Mantle Cell Lymphoma
Sun Yat-sen University
P2
CCC
(53)
Jwcar029
Primary Mediastinal Large B-Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
P2
CCC
(53)
Kras Tcr-Transduced Pbl
Duodenum Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Kras Tcr-Transduced Pbl
Digestive System Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Kras Tcr-Transduced Pbl
Hepatocellular Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Kras Tcr-Transduced Pbl
Small Intestine Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Lifileucel
Bone Sarcoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Dedifferentiated Chondrosarcoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Bone Giant Cell Tumor
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Malignancy In Giant Cell Tumor Of Bone
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Ovarian Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Ovarian Carcinosarcoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Platinum-Resistant Ovarian Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Poorly Differentiated Thyroid Gland Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Osteosarcoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Lifileucel
Thyroid Gland Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P2
CCC
(53)
Showing 351 to 375 of 3,774 assets
Previous
Page 15 of 151
Next